Engage Therapeutics is a pharmaceutical company dedicated exclusively to the epilepsy community. We are developing Staccato Alprazolam, the first epilepsy rescue therapy of its kind that has the ability to stop ongoing seizures.
Member count: 1-10
Total raised: $23M
Founded date: 2017
Investors 2
Date | Name | Website |
- | Lumira Ven... | lumiravent... |
- | LifeSci Ve... | lifesciven... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
27.09.2017 | Series A | $23M | Lumira Ven... | lifesciven... |
Mentions in press and media 8
Date | Title | Description | Category | Author | Source |
12.03.2020 | CureVac f... | → Daniel Menichella, the CEO ... | - | Amber Tong | endpts.com... |
12.03.2020 | Engage The... | SUMMIT, N.J. (GLOBE NEWSWIRE) ... | - | - | lumiravent... |
08.05.2019 | Engage The... | SUMMIT, N.J., May 6, 2019 /PRN... | - | - | lumiravent... |
14.03.2019 | Engage The... | SUMMIT, N.J. (PRNewswire) — En... | - | - | lumiravent... |
27.09.2017 | Engage The... | SUMMIT, N.J.--(BUSINESS WIRE)-... | - | - | citybizlis... |
27.09.2017 | Engage The... | - | - | - | lifesciven... |
27.09.2017 | Engage The... | SUMMIT, NJ, Clinical-stage b... | - | - | vcnewsdail... |
27.09.2017 | Lumira Cap... | SUMMIT, N.J.--(BUSINESS WIRE)-... | - | - | citybizlis... |